Wisdom From Annual Meeting Speakers

Simon Mendelsohn

Nishi Suryavanshi

Bob Horsburgh

Maha Farhat

Simon Mendelsohn

Simon Mendelsohn

RePORT South Africa, discussing the need for systematic screening for asymptomatic TB in household contacts

We are not detecting TB early enough and mostly treating people with more advanced disease. If we want to impact transmission, we need to find TB cases earlier, potentially before they recognize their symptoms.

Nishi Suryavanshi

Nishi Suryavanshi

RePORT India, on implementation research to close the gap on alcohol use among persons with TB

With India having the highest global burden of TB and the third highest burden of HIV, substance use – particularly unhealthy alcohol use – adds another layer of risk and can worsen the health outcomes of people with TB and HIV. Although India’s TB program has made great progress over the years, one important gap still remains: alcohol use is not being systematically addressed.

Bob Horsburgh

Bob Horsburgh

Boston University, on the issue of decreased serum levels of second-line anti-TB drugs in persons living with HIV

A meta-analysis in 2014 concluded that HIV was significantly associated with MDR-TB. We found that HIV-infected participants had lower drug levels and were also more likely to have no detectable drug measured, suggesting they were not taking or absorbing the medication, and this was more common in HIV-infected people.

Maha Farhat

Maha Farhat

Harvard University, speaking on M. tuberculosis lineage and sympatry and human host influences on disease transmission

There are several theories on long-term population genetics, and closest to my heart is co-evolution between TB and its human host. There are now an estimated 10 different human-adapted MTB lineages… Essentially, the lineages distribute differently across the world, and it has been hypothesized that this is related to how they adapt or how they have co-evolved with different human subpopulations.

What's new

Celebrating Dr. Rajita R. Bhavaraju

Celebrating Dr. Rajita R. Bhavaraju

Celebrating Dr. Rajita R. BhavarajuLifetime Service Award RecipientCelebrating Dr. Rajita R. Bhavaraju: Lifetime Service Award RecipientI am pleased to announce that "our own" Rajita Bhavaraju, PhD, MPH, Director of Global Operations for the TB-RePORT International...

read more
Update on Biomarkers Study

Update on Biomarkers Study

update on biomarkers studyAnalysis of Host Biomarkers Associatedwith Adverse TB Treatment Outcomes Across RePORT International SitesAnalysis of Host Biomarkers Associatedwith Adverse TB Treatment Outcomes Across RePORT International Sites Sheetal Verma

read more
RiCC Leadership Group

RiCC Leadership Group

RICC International leadershipCopenhagen | November 18, 2025Meeting Highlights Copenhagen | November 18, 2025 The RePORT International Leadership Group met in Copenhagen on November 18 to review ongoing research activities and strategic priorities across the...

read more